期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Aplastic anemia associated with dyskeratosis congenita treated with antilymphocyte globulin and cyclosporine: a case report
1
作者 Hsiu-MeiHuang Wen-LiangYu +4 位作者 Yu-LunHuang Wei-ShiouHwang Chao-JungTsao Hsiao-ShengLiu guan-chenghuang 《Chinese Medical Journal》 SCIE CAS CSCD 2005年第9期790-792,共3页
Dyskeratosis congenita (DC) is a severe inherited disease characterized by a triad of clinical manifestations including abnormal skin pigmentation, nail dystrophy, and mucosal leukoplakia. 1 Bone marrow failure is th... Dyskeratosis congenita (DC) is a severe inherited disease characterized by a triad of clinical manifestations including abnormal skin pigmentation, nail dystrophy, and mucosal leukoplakia. 1 Bone marrow failure is the principal cause of early mortality, together with an increased predisposition to malignancy and fatal pulmonary complications. According to the dyskeratosis congenita registry, a peripheral blood cytopenia of one or more lineages is reported in 93% of patients, with 51% developing pancytopenia before the age of 10 years. 2 In patients with DC, bone marrow failure or bone marrow failure treatment-associated complications account for 67% of total mortality. 3 Therefore, management of bone marrow failure syndrome is crucial in patients with DC. 展开更多
关键词 dyskeratosis congenita aplastic anemia antilymphocyte globulin immunosuppression therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部